PMS & PMDD

Essential Reads: Neurosteroids, Allopregnanolone and Vulnerability to Depression in Women

This article focuses on how GABA-ergic neurotransmitter systems may modulate the interaction between reproductive steroid and sex steroid systems, and sheds light on the role allopregnanolone may play in medicating vulnerability to depression. 

By |2021-07-14T09:53:19-04:00July 14th, 2021|Depressive Disorders, Essential Reads, Menopausal Symptoms, PMS & PMDD, Postpartum Psychiatric Disorders|Comments Off on Essential Reads: Neurosteroids, Allopregnanolone and Vulnerability to Depression in Women

Essential Reads: A Clinical Guide for the Diagnosis and Treatment of PMDD

In an evidence-based review published in 2012, Laura Wakil, Samantha Meltzer-Brody, and Susan Girdler present a thorough review of premenstrual dysphoric disorder (PMDD), reviewing its diagnosis and treatment options.

By |2021-06-16T09:29:12-04:00June 16th, 2021|Diagnosis & Screening, Essential Reads, PMS & PMDD, Treatment|Comments Off on Essential Reads: A Clinical Guide for the Diagnosis and Treatment of PMDD

Food for Thought: Are Women with ADHD at Increased Risk for Hormonally Mediated Mood Disorders?

While for some adults, attention-deficit/hyperactivity disorder (ADHD) is relatively mild and, with effective treatment, does not have a significant impact on overall functioning or quality of life.  However, it is noteworthy that the majority of [...]

By |2021-05-06T15:06:53-04:00February 2nd, 2021|ADHD, PMS & PMDD, Postpartum Psychiatric Disorders, Prevalence & Risk Factors|Comments Off on Food for Thought: Are Women with ADHD at Increased Risk for Hormonally Mediated Mood Disorders?

A Novel Treatment for PMDD: Ulipristal Acetate, a Progesterone Receptor Modulator

While many women experience physical symptoms prior to the onset of their period or premenstrual syndrome (PMS), a smaller subset of women suffer from Premenstrual Dysphoric Disorder (PMDD), a more severe form of premenstrual [...]

By |2021-01-04T11:20:55-04:00January 5th, 2021|Medication, PMS & PMDD, Treatment|Comments Off on A Novel Treatment for PMDD: Ulipristal Acetate, a Progesterone Receptor Modulator

Essential Reads:  Ovarian Suppression for the Treatment of Severe PMDD

While many women experience physical symptoms prior to the onset of their period or premenstrual syndrome (PMS), a smaller subset of women suffer from Premenstrual Dysphoric Disorder (PMDD), a more severe form of premenstrual [...]

By |2021-05-06T15:10:07-04:00December 23rd, 2020|Essential Reads, Hormone Therapy, PMS & PMDD, Treatment|Comments Off on Essential Reads:  Ovarian Suppression for the Treatment of Severe PMDD

Preliminary Data Supporting the Use of Mindfulness-Based Cognitive Therapy for Premenstrual Symptoms

There is excellent data to support the use of selective serotonin and serotonin- norepinephrine reuptake inhibitors (SSRIs and SNRIs) for the treatment of premenstrual dysphoric disorder (PMDD); however, many women do not want to [...]

By |2020-08-13T14:47:12-04:00April 21st, 2020|PMS & PMDD, Psychotherapy, Treatment|Comments Off on Preliminary Data Supporting the Use of Mindfulness-Based Cognitive Therapy for Premenstrual Symptoms

Internet-Based Cognitive-Behavioural Therapy for Women with PMDD

There is excellent data to support the use of selective serotonin and serotonin-norepinephrine reuptake inhibitors (SSRIs and SNRIs) for the treatment of premenstrual dysphoric disorder (PMDD); however, many women do not want to take [...]

By |2020-08-13T14:27:14-04:00March 5th, 2020|PMS & PMDD, Psychotherapy, Treatment|Comments Off on Internet-Based Cognitive-Behavioural Therapy for Women with PMDD
Go to Top